
SURMOUNT 1-4 post hoc analysis: weight and waist circumference in people with different durations of overweight or obesity
In this medfyle
A post hoc analysis of SURMOUNT-1 to -4 was presented at ECO 2024, showing that across the trials tirzepatide reduced body weight and waist circumference in people with overweight or obesity regardless of disease duration.
About this Medfyle
©2024 Medfyle. All rights reserved.
Source: Muscogiuri G, Pedersen SD, Jaouimaa F, et al. Tirzepatide reduced body weight and waist circumference in people with overweight or obesity regardless of disease duration: post hoc analysis of the SURMOUNT 1-4 trials. Obes Facts 2024;17(suppl 1):AS12.03.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.